UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027738
Receipt number R000031782
Scientific Title Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Date of disclosure of the study information 2017/07/01
Last modified on 2017/06/13 13:39:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.

Acronym

Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.

Scientific Title

Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.

Scientific Title:Acronym

Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.

Region

Japan


Condition

Condition

hematological tumor

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We want to clarify intention, attitude and hope to stop blood transfusion in advanced blood tumor patients through personal interview.

Basic objectives2

Others

Basic objectives -Others

We want to consider clinical guidelines about blood transfusion of advanced bllod tumor patients.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intention and attitude to blood transfusion.
When do they want to stop blood transfusion. In that case, how to tell or be told medical staff about this hope.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Advanced blood tumor patients.
Patients who were told their disease is not curerable from the doctor.
Patients receiving regular blood transfusion.

Key exclusion criteria

Patients who can not speak Japanese.
Patients who do not know anout their disease and future prospects.
Patients recieving temporary blood transfusion because of active bleeding and anemia.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiyuki Kizawa

Organization

Kobe university graduate School of medicine

Division name

Department of palliative medicine

Zip code


Address

7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, Japan

TEL

0783826531

Email

kizawa-ysyk@umin.org


Public contact

Name of contact person

1st name
Middle name
Last name Asami Shimada

Organization

Kobe university graduate School of medicine

Division name

Department of palliative medicine

Zip code


Address

7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, Japan

TEL

0783826531

Homepage URL


Email

ashimada@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe university graduate School of medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2017 Year 06 Month 13 Day

Last modified on

2017 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031782


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name